RESI Philadelphia: An Agenda for Investing in Life Science’s Cutting Edge

7 Mar

By Lucy Parkinson, VP of Investor Research, LSN

Life Science Nation is looking ahead to the summer, when we’ll be joining thousands of executives from the life science and pharma industries in Philadelphia on June 3rd during the BIO International Convention.  By bringing the Redefining Early Stage Investments (RESI) conference to Philadelphia in June, LSN will provide a focused early stage venue for investors to find new technologies and connect with early stage entrepreneurs from all around the world.  RESI’s agenda of panels and workshops will provide fundraising CEOs with guidance on how to find capital even for the most novel potential breakthrough product.  Panels include emerging areas of technology like Investing in Cell & Gene Therapy, Mental & Behavioral Health and AI in Healthcare, and key potential sources of capital like Asia Corporates & Strategics, Korea Investors and Angels & Family Offices.  At RESI Philadelphia, entrepreneurs can both meet investors and hear candid, insightful discussion on what makes investors tick. If you’d like to join us during BIO, register here.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: